Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes

M. Eslam, A. Mangia, T. Berg, H.L.Y. Chan, W.L. Irving, G.J. Dore, M.L. Abate, E. Bugianesi, Leon Adams, M.A.M. Najim, L. Miele, M. Weltman, L. Mollison, W. Cheng, S. Riordan, J. Fischer, M. Romero-Gomez, U. Spengler, J. Nattermann, A. RahmeD. Sheridan, D.R. Booth, D. Mcleod, E. Powell, C. Liddle, M.W. Douglas, D. Van Der Poorten, J. George, R. White, A. Rojas, R. Gallego-Duran, M. Bassendine, V.W.S. Wong, C. Rosso, L. Mezzabotta, R. Leung, B. Malik, G. Matthews, T. Applegate, J. Grebely, V. Fragomeli, J.R. Jonsson, R. Santaro

    Research output: Contribution to journalArticlepeer-review

    99 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science

    Immunology and Microbiology